Clinical Trial

Hemoadsorption for Severe Ischemic Stroke

Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized-controlled, open-label, blinded endpoint clinical trial that aims to evaluate the efficacy and safety of hemoadsorption for severe ischemic stroke
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-11; most recent amendment 2026-05-13.
Status change: Not Yet Recruiting → Recruiting 2026-05-13
Trial Details
NCT Number NCT07127484
Lead Sponsor First Affiliated Hospital of Wannan Medical College
Collaborators: Anqing Municipal Hospital, Beijing Tiantan Hospital, Gansu Provincial Central Hospital, Baotou Central Hospital, The NO.1 People's Hospital of Shizuishan, Fuyang people's hospital, Second People's Hospital of Hefei City, The First Affiliated Hospital of Zhengzhou University, THE SECOND PEOPLE'S HOSPITAL, WUHU
Conditions Ischemic Stroke, Hemoadsorption
Enrollment 116 participants
Start Date 2026-01-05
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-05-15